FDA panel recommends Moderna booster shot for at-risk adults

The FDA still needs to approve the recommendation.
Published: Oct. 14, 2021 at 4:44 PM EDT|Updated: Oct. 14, 2021 at 10:26 PM EDT
Email This Link
Share on Pinterest
Share on LinkedIn

CLEVELAND, Ohio (WOIO) - An FDA panel has endorsed the Moderna COVID-19 booster shot for at-risk adults. According to Dr. Claudia Hoyen, Director of Pediatric Infection Control at UH Rainbow Babies and Children’s Hospital, there is an expectation that the Moderna booster will receive FDA approval sometime next week.

The panel of FDA health advisors endorsed the shot, which would be recommended for a lower-dose booster for seniors and other high-risk groups. This would be for anyone with a Moderna shot that received it at least six months ago. A final decision on this is expected next week. U.S. officials stress that the priority is to get shots to the 66 million unvaccinated Americans who are eligible.

Currently the Pfizer shot is the only one that has been approved for a booster. The approval for the Pfizer started at this same level as the Moderna. Dr. Hoyen said that the Johnson & Johnson booster could also see a similar route.

Currently, Ohio has administered around 300,000 boosters and more than 6,389,000 have received at least one dose of the vaccine. Dr. Hoyen is hoping more get the vaccine before the holiday season starts, something she thinks could be seen as more boosters become available.

Copyright 2021 WOIO. All rights reserved.